Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516374 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Hard CopyAdd to Basket
Live Chat Live Help Software for Website

Assessment of Mesterolone Therapy in Oligospermic Males. Edition No. 1

VDM Publishing House, Aug 2010, Pages: 112


  Description  
   Authors   
    
    
    
     
  Enquire before Buying   
  Send to a Friend   

Infertility is known to us since ages. There is an alarming rate of increase of infertility cases especially in the young urban males in India. Keeping this in mind we took up this study to evaluate the role of Mesterolone in oligospermic males . We also compared the role of Mesterolone and the effects of a combined therapy of mesterolone and clomiphene citrate on semen parameters, effect on pituitary axis and liver function.Thirty males with idiopathic oligospermia were included in this study. Out of the thirty subjects,10 were given only tab mesterolone 50 mg b.d .Ten were given 50 mg of tab mesterolone 1 b.d and 25 mg of clomiphene citrate 1 o.d. The remaining 10 were used as controls and given tab vitamin C 75 mg b.d for 4 months. A follow- up study was conducted at the end of 100 , 150 and 200 days for group A,B and C respectively.A complete semen analysis including the differential count was done. The study showed only mesterolone was not effective in comparison to the combination of mesterolone and clomiphene citrate which was much effective and showed 40% increase in sperm concentration.



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds